SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Anika Therapeutics, Inc. (ANIK)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
4.6 / 10
Letters
2
Latest Activity
Feb. 26, 2026
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
1.1
Notable 8-K Count
2

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jul. 24, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Anika Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. In their correspondence, they remind the company and its mana… Read Filing EDGAR
Jul. 17, 2025 CORRESP Neutral/Informational Moderate Anika Therapeutics, Inc. submitted a response to the SEC regarding comments on their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested additional disclosure… Read Filing EDGAR
Jun. 18, 2025 UPLOAD Concern from SEC High The SEC has conducted a limited review of Anika Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024, focusing on financial statements and related disclosure… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.